We are live on ! Find out more
AF

Avanza Fonder Portfolio holdings

AUM $4.59B
1-Year Est. Return 41.03%
This Fund
S&P 500
This Quarter Est. Return
-4.89%
1 Year Est. Return
+41.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.05B
AUM Growth
-$320M
Cap. Flow
-$135M
Cap. Flow %
-4.44%
Top 10 Hldgs %
40.33%
Holding
468
New
31
Increased
49
Reduced
321
Closed
8

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$20.2M
2
ACN icon
Accenture
ACN
+$14.8M
3
MDT icon
Medtronic
MDT
+$11M
4
CB icon
Chubb
CB
+$7.13M
5
TT icon
Trane Technologies
TT
+$7.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$21.5M
2
NVDA icon
NVIDIA
NVDA
+$19.3M
3
AMZN icon
Amazon
AMZN
+$14.6M
4
AAPL icon
Apple
AAPL
+$11.2M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.05M

Sector Composition

Rank Sector Weight
1 Technology 34.06%
2 Consumer Discretionary 14.72%
3 Financials 13.56%
4 Healthcare 12.28%
5 Communication Services 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSC icon
426
WillScot Mobile Mini Holdings
WSC
$4.83B
$119K ﹤0.01%
4,088
-2,596
-39% -$88.3K
MRUS
427
DELISTED
Merus
MRUS
$118K ﹤0.01%
+2,749
New +$120K
ERII icon
428
Energy Recovery
ERII
$470M
$116K ﹤0.01%
7,274
HCAT icon
429
Health Catalyst
HCAT
$168M
$116K ﹤0.01%
26,050
SMMT icon
430
Summit Therapeutics
SMMT
$11B
$113K ﹤0.01%
5,535
-910
-14% -$18.3K
NAMS icon
431
NewAmsterdam Pharma
NAMS
$3.22B
$113K ﹤0.01%
+6,205
New +$138K
ACLX
432
DELISTED
Arcellx
ACLX
$110K ﹤0.01%
1,643
-755
-31% -$51.1K
ALRM icon
433
Alarm.com
ALRM
$2.76B
$110K ﹤0.01%
1,975
LEN.B icon
434
Lennar Class B
LEN.B
$20.6B
$109K ﹤0.01%
994
-52
-5% -$6.2K
KAI icon
435
Kadant
KAI
$3.95B
$104K ﹤0.01%
296
-168
-36% -$61K
PACB icon
436
Pacific Biosciences
PACB
$447M
$103K ﹤0.01%
80,727
+4,319
+6% +$6.63K
RVMD icon
437
Revolution Medicines
RVMD
$41.1B
$99.5K ﹤0.01%
2,877
-1,073
-27% -$43.6K
VRNA
438
DELISTED
Verona Pharma
VRNA
$99.5K ﹤0.01%
+1,651
New +$98.8K
GPK icon
439
Graphic Packaging
GPK
$3.52B
$96.4K ﹤0.01%
3,665
-3,341
-48% -$89.4K
HRMY icon
440
Harmony Biosciences
HRMY
$2.25B
$95.1K ﹤0.01%
2,924
-1,276
-30% -$45.7K
LAUR icon
441
Laureate Education
LAUR
$5.2B
$93K ﹤0.01%
+4,457
New +$86.1K
BCAX
442
Bicara Therapeutics
BCAX
$1.71B
$88.2K ﹤0.01%
+6,653
New +$88.3K
JANX icon
443
Janux Therapeutics
JANX
$973M
$86.1K ﹤0.01%
3,049
+444
+17% +$16.7K
BFAM icon
444
Bright Horizons
BFAM
$3.98B
$83.8K ﹤0.01%
652
-184
-22% -$22.6K
CMI icon
445
Cummins
CMI
$87.8B
$76.8K ﹤0.01%
240
BIOX icon
446
Bioceres Crop Solutions
BIOX
$24.1M
$72.1K ﹤0.01%
+16,065
New +$88.4K
ARQ icon
447
Arq
ARQ
$88.9M
$69.8K ﹤0.01%
16,615
+7,615
+85% +$43.2K
MREO
448
Mereo BioPharma
MREO
$51.4M
$66.6K ﹤0.01%
28,121
+8,521
+43% +$24.1K
GXO icon
449
GXO Logistics
GXO
$6.03B
$66.5K ﹤0.01%
1,658
-1,029
-38% -$43K
ONT
450
Onterris Inc
ONT
$826M
$63.9K ﹤0.01%
4,700
-960
-17% -$18.3K

Similar funds

Avanza Fonder's Q1 2025 Portfolio in Review

As of Q1 2025, Avanza Fonder held 468 positions worth $3.05B, down 9.5% from $3.37B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Avanza Fonder withdrew a net $135M in Q1 2025, closing 8 positions and reducing 321 holdings. Its most notable exit was SoFi Technologies, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Avanza Fonder opened a new position in Linde worth $21.1M.

  • Avanza Fonder's largest Q1 2025 buy was Linde: 44,860 shares worth $21.1M.
  • Avanza Fonder added most to Tesla in Q1 2025, an estimated $3.07M increase.
  • Avanza Fonder's biggest Q1 2025 reduction was Microsoft, cutting an estimated $21.5M.
  • Avanza Fonder fully exited SoFi Technologies in Q1 2025, selling an estimated $1.01M.
  • Avanza Fonder's ten largest holdings make up 40% of its $3.05B portfolio in Q1 2025.
  • Avanza Fonder opened 31 new positions and closed 8 in Q1 2025.
  • Avanza Fonder's portfolio value fell 9.5% quarter-over-quarter to $3.05B.

Based on Avanza Fonder's 13F filing for Q1 2025, filed 15 Apr 2025.